Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
169.20    -1.20 (-0.70%)
Bid:
168.80
Ask:
169.40
Spread: 0.60 (0.355%)
Market Cap: £207.63m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Directorate Change

2 Apr 2024 12:10

RNS Number : 9781I
SThree plc
02 April 2024
 

2 April 2024

 

SThree plc

 

Directorate Change

 

SThree plc, the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics (STEM), is pleased to announce that it will appoint Sanjeevan Bala as an Independent Non-Executive Director with effect from the conclusion of the Annual General Meeting on 25 April 2024, in line with its previously stated plan to recruit a new Non-Executive.

 

Sanjeevan has extensive experience driving customer-centric technology transformation, having most recently been responsible for driving the digital data and AI transformation of the UK's largest commercial broadcaster and media company, ITV plc as the Group Chief Data and AI Officer. Prior to this, Sanjeevan was Head of Data Science at Channel 4 and held senior roles at Clear Cell Group and Dunhumby, a global leader in Customer Data Science.

 

Sanjeevan is currently a Non-Executive Director and the Designated Workforce Engagement NED at Bakkavor Group plc, Co-Chair of the Chief Data and AI Office Board at Evanta, a Gartner Company and on the Advisory Board of DataIQ.

 

On joining the Board, Sanjeevan will also be appointed as a member of the Audit & Risk, Nominations and Remuneration Committees.

 

James Bilefield, Chairman, commented: 

 

"I am delighted to welcome Sanjeevan to SThree and the Board. Sanjeevan is a highly experienced multi award-winning data and analytics professional with a proven track record of driving customer-centric business transformations through the strategic use of data. He brings with him extensive strategic and commercial experience which will be particularly relevant as we continue to roll out our Technology Improvement Programme, positioning us as game-changers in the market and demonstrating our ambition to be digital-first innovators. We look forward to working with him as the Group continues to execute its growth strategy."

 

 

Sanjeevan Bala commented:

 

"Having spent most of my career in STEM and witnessing first-hand the global demand for these skills expand exponentially, it feels like an incredibly exciting time to be joining SThree. The SThree team talks to global megatrends that underpin the demand for STEM and flexible talent and they couldn't be more correct. I look forward to working with the Board and forward-thinking leadership team to capitalise on this structural opportunity."

 

Notes:

This disclosure is given in accordance with LR 9.6.11 R of the Listing Rules. There is no further information to be disclosed pursuant to Listing Rule 9.6.13. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUAUCUPCGGP
Date   Source Headline
2nd Mar 202611:15 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 202612:15 pmRNSDirector/PDMR Shareholding
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSCommencement of Share Buyback Programme
2nd Feb 20261:24 pmRNSTotal Voting Rights
27th Jan 20267:00 amRNSFY25 Final Results
13th Jan 20269:08 amRNSDirector/PDMR Shareholding
2nd Jan 202611:56 amRNSTotal Voting Rights
2nd Jan 202611:45 amRNSPurchase of shares into the EBT
2nd Jan 202610:56 amRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSFY25 Full Year Trading Update
15th Dec 20252:11 pmRNSHolding(s) in Company
15th Dec 202510:14 amRNSDirector/PDMR Shareholding
11th Dec 20254:28 pmRNSHolding(s) in Company
9th Dec 20255:35 pmRNSHolding(s) in Company
1st Dec 202512:14 pmRNSTotal Voting Rights
26th Nov 20258:00 amRNSDirector Declaration
26th Nov 20257:00 amRNSDirectorate change
13th Nov 20253:40 pmRNSDirector/PDMR Shareholding
7th Nov 20253:57 pmRNSHolding(s) in Company
31st Oct 202511:42 amRNSTotal Voting Rights
24th Oct 20259:37 amRNSHolding(s) in Company
22nd Oct 20251:03 pmRNSHolding(s) in Company
14th Oct 20254:28 pmRNSDirector/PDMR Shareholding
6th Oct 202511:04 amRNSDirector Declaration
1st Oct 202512:09 pmRNSResult of Meeting
30th Sep 202512:48 pmRNSTotal Voting Rights
26th Sep 202510:41 amRNSHolding(s) in Company
17th Sep 20259:30 amRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSFY25 Q3 Trading Update
15th Sep 202511:00 amRNSDirector/PDMR Shareholding
10th Sep 20251:59 pmRNSHolding(s) in Company
10th Sep 202510:45 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of GM
1st Sep 202511:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.